• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZYB

ZYBER HOLDINGS LTD - Announcements

0.00% ! 1.0¢
Currently unlisted.
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements



Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ZYB Appendix 3B28/03/18
ZYB Reinstatement to Official QuotationPRICE SENSITIVE19/03/18
ZYB Corporate UpdatePRICE SENSITIVE19/03/18
ZYB Zyber Dual Lists on Frankfurt Stock Exchange19/03/18
ZYB Request for Extension of Suspension14/03/18
ZYB Becoming a substantial holder01/03/18
ZYB Appendix 4D & Half Yearly Accounts and ReportPRICE SENSITIVE28/02/18
ZYB Request for Extension of Suspension28/02/18
ZYB Final Director's Interest Notice27/02/18
ZYB Initial Director's Interest Notice27/02/18
ZYB Change in substantial holding27/02/18
ZYB Change in substantial holding23/02/18
ZYB Trading HaltPRICE SENSITIVE14/02/18
ZYB Appendix 3B
28/03/18
ZYB Reinstatement to Official Quotation
19/03/18PRICE SENSITIVE
ZYB Corporate Update
19/03/18PRICE SENSITIVE
ZYB Zyber Dual Lists on Frankfurt Stock Exchange
19/03/18
ZYB Request for Extension of Suspension
14/03/18
ZYB Becoming a substantial holder
01/03/18
ZYB Appendix 4D & Half Yearly Accounts and Report
28/02/18PRICE SENSITIVE
ZYB Request for Extension of Suspension
28/02/18
ZYB Final Director's Interest Notice
27/02/18
ZYB Initial Director's Interest Notice
27/02/18
ZYB Change in substantial holding
27/02/18
ZYB Change in substantial holding
23/02/18
ZYB Trading Halt
14/02/18PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Patrys secures ethics approval for Phase 1A clinical trial on delirium candidate

Patrys has received HREC approval to commence its Phase 1A clinical trial of RLS-2202 for the treatment of delirium in acute care settings.
Imricor Med and Philips launch commercial iMR lab solution Imricor Medical Systems has launched a new Interventional MR (iMR) lab solution in collaboration with Dutch company Royal Philips.
Lodestar Minerals' drilling results strengthen IOCG model at Three Saints Lodestar Minerals has received positive final assay results for the second diamond drill hole at the Three Saints IOCG project in Chile.
Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27 Right now, the US-Israel-Iranian war in the Middle East and the ongoing war in Ukraine are both increasing global demand for a critical mineral vital for national security and defence: tungsten. While not the whole story of its appeal, tungsten has the highest melting point of any metal and is hi...
Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus Askari Metals Executive Director Gino D’Anna discusses the company’s Ethiopia strategy, permitting progress, and broader portfolio ambitions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.